Review of the psoriatic arthritis working group at OMERACT 12: A report from the GRAPPA 2014 annual meeting

Journal of Rheumatology

Volumn 42, Issue 6, 2015, Pages 1048-1051

  Tillett, William ^a   Eder, Lihi ^b   Goel, Niti ^c   De Wit, Maarten ^d   Ogdie, Alexis ^e   Orbai, Ana Maria ^f   Campbell, Willemina ^g   Fitzgerald, Oliver ^h   McHugh, Neil J ⁱ   Gladman, Dafna D ^j   Strand, Vibeke ^k   Mease, Philip J ^l  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^h University of Bath   (United Kingdom)

ⁱ UNIVERSITY HEALTH NETWORK   (Canada)

^j STANFORD UNIVERSITY   (United States)

^k Rheumatology Associates   (United States)

^l UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

OMERACT; OUTCOME MEASUREMENT; PATIENT PARTICIPATION; PSORIATIC ARTHRITIS

Indexed keywords

CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; DACTYLITIS; ENTHESITIS; FATIGUE; HEALTH CARE ORGANIZATION; HUMAN; MUSCULOSKELETAL DISEASE ASSESSMENT; MUSCULOSKELETAL SYSTEM PARAMETERS; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PRIORITY JOURNAL; PSORIASIS ACTIVITY AND SEVERITY INDEX; PSORIATIC ARTHRITIS; SWOLLEN JOINT COUNT; TENDER JOINT COUNT;

EID: 84940508613     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150131     Document Type: Conference Paper

References (22)

1. Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70.
2. Coates LC, Fitzgerald O, Mease PJ, Gladman DD, Strand V, Goel N, et al. Development of a disease activity and responder index for psoriatic arthritis-Report of the Psoriatic Arthritis Module at OMERACT 11. J Rheumatol 2014;41:782-91.
3. Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res 2011;63 Suppl 11:S64-85.
4. OMERACT. Guiding principles for patient research partner participation in OMERACT. [Internet. Accessed March 13, 2015.] Available from: www.omeract.org/patient-research-partners.html
5. OMERACT Handbook. July 2014. [Internet. Accessed March 13, 2015.] Available from: www.omeract.org/publications
6. Bingham CO III, Alten R, de Wit MP. The importance of patient participation in measuring rheumatoid arthritis flares. Ann Rheum Dis 2012;71:1107-9.
7. de Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open 2013;3:e002241.
8. de Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis 2011;70:722-6.
9. Tillett W, Adebajo A, Brooke M, Campbell W, Coates LC, FitzGerald O, et al. Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep 2014;16:418.
10. Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 2014;73:1012-9.
11. Tillett W, Eder L, Goel N, De Wit M, Gladman DD, FitzGerald O, et al. Enhanced patient involvement and the need to update the psoriatic arthritis core set-report from the Psoriatic Arthritis workshop at OMERACT 2014. J Rheumatol 2015;42 (in press).
12. Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, et al. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis Rheum 2013;65:1504-9.
13. Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005;32:1745-50.
14. Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, et al. International spondyloarthritis interobserver reliability exercise-the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007;34:1740-5.
15. Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 2007;66:936-9.
16. Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum 2009;61:1235-42.
17. de Wit M, Campbell W, FitzGerald O, Gladman DD, Helliwell PS, James J, et al. Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 annual meeting. J Rheumatol 2014;41:1206-11.
18. de Wit M, Campbell W, Orbai AM, Tillett W, FitzGerald O, Gladman DD, et al. Building bridges between researchers and patient research partners: a report from the GRAPPA 2014 annual meeting. J Rheumatol 2015;42:1021-6.
19. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745-53.
20. Gladman DD, Ziouzina O, Thavaneswaran A, Chandran V. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. J Rheumatol 2013;40:1357-9.
21. Walsh JA, McFadden ML, Morgan MD, Sawitzke AD, Duffin KC, Krueger GG, et al. Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol 2014;41:1670-4.
22. Sakkas LI, Alexiou I, Simopoulou T, Vlychou M. Enthesitis in psoriatic arthritis. Semin Arthritis Rheum 2013;43:325-34.